Navigation Links
Hoosier Oncology Group Selects OnCore to Support Clinical Trials Network
Date:8/7/2013

MADISON, Wis. and INDIANAPOLIS, Aug. 7, 2013 /PRNewswire/ -- Forte Research Systems, developer of specialized clinical research software, and the Hoosier Oncology Group ("the HOG"), a leading not-for-profit company specializing in the management of investigator-initiated clinical trials, are pleased to announce that HOG has selected Forte's OnCore® Enterprise Research system to support the trials of the newly formed Big Ten Cancer Research Consortium, as well as the HOG's additional portfolio of clinical trials.

(Logo: http://photos.prnewswire.com/prnh/20101115/CG02078LOGO)

The HOG will use functionality within OnCore to streamline the administration of trials, including financials management and electronic data capture, across its network.

Collaboration in Oncology Clinical Trials
The HOG supports more than 400 research center physicians and practitioners throughout its network. It is also the administrative headquarters of the Big Ten Cancer Research Consortium, a network consisting of 12 academic cancer centers and research universities that have come together to collaborate and conduct highly translational oncology trials.

Officially launched in June, the new consortium leverages its members' collective expertise and streamlines the process of conducting trials. Through their combined efforts, the centers have access to more than 30,000 new patients each year.  

"The Big Ten Cancer Research Consortium is a new collaborative endeavor that has been created to transform the way oncology trials are conducted," said Tim Breen, Data Systems Director at the HOG. "It was important to select the right system to accomplish these goals, and we decided that the OnCore system was the best solution."

Srini Kalluri, Founder, CEO, and Chief Customer Officer at Forte, believes the selection of OnCore to support the consortium represents an opportunity to enhance existing relationships with institutions while building new ones. "We are pleased to have already been working with more than half of the institutions in the Big Ten Cancer Research Consortium, and we are excited to expand our support to the other institutions involved," he said. "The collaboration is an exciting new endeavor in clinical research, and we are thrilled to be a part of it."  

About Forte Research Systems, Inc.
Founded in 2000 and headquartered in Madison, Wisconsin, Forte Research Systems, Inc. develops and markets clinical and translational research software for better research compliance, patient safety, operational efficiency, and financial viability. The company's flagship product, the OnCore® Enterprise Research solution, has been meeting the needs of academic medical centers, CTSAs, research hospitals, and cancer centers for over a dozen years. Now, its proven electronic data capture platform is available as a stand-alone hosted solution for academic researchers, Overture™ EDC. For Research Sites, Site Networks, and SMOs, Forte offers Allegro® CTMS. Forte is also host to the Clinical Research Blog and other resources for individuals interested in excellence in clinical research operations.

About Hoosier Oncology Group
The Hoosier Oncology Group, Inc. (affectionately nicknamed "the HOG") consists of a working association of over 400 dedicated community and research center physicians and clinical research practitioners. The HOG is committed to improving therapy for cancer patients through clinical research throughout its network.


'/>"/>
SOURCE Forte Research Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Orfit Launches Open Face Hybrid Mask For Patient Immobilization In Radiation Oncology
2. Life Technologies and RainTree Oncology Services Announce Collaboration to Bring Molecular Tumor Testing to Community Oncologists
3. Astellas Appoints New Senior Vice President of Global Oncology Development
4. Oncology remains most restrictive specialty for second year
5. Using Success & Failure Roadmap Paves the Way for Positive New Product Launches in Oncology
6. Accelovance Primed to Achieve Leadership in Oncology Clinical Trials
7. Loxo Oncology And Array BioPharma Announce License And Collaboration Agreement
8. Sorrento Therapeutics and IGDRASOL to Present Late Stage Clinical Data Updates on their Oncology Nanomedicine Platform at the Joint Meeting of the European Foundation for Clinical Nanomedicine and European Technology Platform on Nanomedicine in Base
9. AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
10. PRISM Pharma Closes $15 million Series C Financing to Advance PRI-724 into Non-oncology Indications
11. Sorrento Therapeutics Receives Frost & Sullivans Prestigious 2013 Global Investment Opportunity Award in the Oncology Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 19, 2017 The Global Effective Microorganisms ... 2022 report has covered and analysed the potential of Global ... market size, shares and growth factors. The report identifies and ... opportunities in the global market. ... Browse 152 Tables and Figures, 6 Major Company Profiles, ...
(Date:4/19/2017)... , April 19, 2017  Novartis today ... the National Heart, Lung, and Blood Institute (NHLBI) ... that 58% of patients with treatment-naïve severe aplastic ... when treated with eltrombopag at the initiation of ... The study evaluated three sequential treatment groups, or ...
(Date:4/18/2017)... April 18, 2017 Viverae ® , a ... the integration of IBM ® Watson Campaign Automation, ... targeted communications for a personalized experience. Through digital engagement, ... their health in real time. The enhanced experience drives ... to members, wherever they are in their journey to ...
Breaking Medicine Technology:
(Date:4/25/2017)... NY (PRWEB) , ... April 25, 2017 , ... A ... stress at work can also decrease overall productivity and performance in the workplace. The ... employees. , During the last few weeks of April, Clearview Resolution Services will be ...
(Date:4/25/2017)... FL (PRWEB) , ... April 25, 2017 , ... Lake ... their smiles by using Invisalign® in Lutz, FL. With the help of ... health and aesthetics with fewer potential complications, more discretion and less pain. , ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers of America ... with a reputable physician in their area, announces the launch of a new and ... patients who are looking for reputable physicians to help them with back or neck ...
(Date:4/25/2017)... ... ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley Bobrow will be ... to publish in summer 2017. , Dr. Bobrow, MD, FACEP, FAHA, is an ... Medicine. He also serves as Medical Director for the Bureau of Emergency Medical Services ...
(Date:4/24/2017)... ... ... Emmanuel College is introducing enhancements to its RN-to-BSN Degree ... fall of 2017, Emmanuel’s program will allow registered nurses (RN)s to earn a Bachelor ... as little as $14,528. These changes will enable nurses to complete their degree in ...
Breaking Medicine News(10 mins):